Abstract
A case of surgically created splenorenal shunt complicated with shunt myelopathy was successfully managed by placement of a stent graft within the splenic vein to close the portosystemic shunt and alleviate myelopathy. To our knowledge, this is the first report of a case of shunt myelopathy in a patient with noncirrhotic portal fibrosis without cirrhosis treated by a novel technique wherein a transjugular intrahepatic route was adopted to deploy the stent graft.
This is a preview of subscription content, log in via an institution to check access.
References
Conn HO, Rossle M, Levy L et al (2006) Portosystemic myelopathy: spastic paraparesis after portosystemic shunting. Scand J Gastroenterol 41:619–625
Wang MQ, Dake MD, Cui ZP et al (2001) Portal systemic myelopathy after transjugular portosystemic shunt creation: report of four cases. J Vasc Interv Radiol 12:879–881
Koo JE, Lim YS, Myung SJ et al (2008) Hepatic myelopathy as a presenting neurological complication in patients with cirrhosis and spontaneous splenorenal shunt. Korean J Hepatol 14:89–96
O’Brien J, Staples C, Florin T (2010) Trouble with a shunt: alcohol and spastic paraparesis. Hepatic myelopathy. Gastroenterology 139(1099):1428
Panicker J, Sinha S, Taly AB et al (2006) Hepatic myelopathy: a rare complication following extrahepatic portal vein occlusion and lienorenal shunt. Neurol India 54:298–300
Pinarbasi B, Kaymakoglu S, Matur Z et al (2009) Are acquired hepatocerebral degeneration and hepatic myelopathy reversible? J Clin Gastroenterol 43:176–181
Litvin S, Atar E, Knizhnik M et al (2010) Stent graft closure of a high flow splenorenal shunt after liver transplantation. Diagn Interv Radiol 16:312–314
Cwikiel W (2006) Interventional procedures involving portal vein circulation: a review. Acta Radiol 47:145–156
Qu B, Liu C, Guo L et al (2009) The role of liver transplantation in the treatment of hepatic myelopathy: case report with review of the literature. Transplant Proc 41:1987–1989
Caldwell C, Werdiger N, Jakab S et al (2010) Use of model for end-stage liver disease exception points for early liver transplantation and successful reversal of hepatic myelopathy with a review of the literature. Liver Transpl 16:818–826
Weissenborn K, Tietge UJF, Bokemeyer M et al (2003) Liver transplantation improves hepatic myelopathy: evidence by three cases. Gastroenterology 124:346–351
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jain, D., Arora, A., Deka, P. et al. Treatment of Portosystemic Shunt Myelopathy with a Stent Graft Deployed through a Transjugular Intrahepatic Route. Cardiovasc Intervent Radiol 36, 1161–1164 (2013). https://doi.org/10.1007/s00270-012-0475-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-012-0475-0